Business Update Neutral

2026-08-17 20:00

- Schedule of Analyst / Institutional Investor Group Meeting - Date: 21st August 2026 - Time: 10:00 AM onwards - Venue: Baroda, Gujarat

Business Update Positive

2026-08-17 19:38

- Additional 25 million pen capacity expected operational by September end, increasing total pen injector capacity to approximately 75 million pens per annum. - Management is confident of exceeding full year guidance for pen sales, anticipating beyond 36 million units. - Gross margin, which saw a sequential decline in Q1 due to commodity prices and freight, is expected to normalize by Q3. - Healthcare segment is now the largest business segment (51% of revenue) and is expected to continue robust growth. - Developing new products including reusable auto-injectors (testing soon, showcasing at CPHI Milan), emergency use auto-injectors (program closure by end of FY27), and on-body injectors. - Plans for a new Consumer Electronics plant with an investment of ₹80-100 crores and ₹5 crores for Semiconductor Trays in existing facility. - Appointed dedicated business development heads for Europe and North America to pursue partnerships with major global pharmaceutical companies.

Business Update Neutral

2026-08-10 20:29

- Audio recording of the Earnings Call held on August 10, 2026, has been uploaded to the company's website. The transcript of the call will be submitted separately.

Governance Positive

2026-08-08 19:38

- Board Meeting on August 8, 2026: Approved Q1 FY27 financial results; Re-appointed MD Amit Mahendra Sanghvi for 5 years (Oct 2026-Sep 2031). - Fixed September 11, 2026, as Record Date for FY26 final dividend; Approved revised Insider Trading Code.

Financials Positive

2026-08-08 19:33

- Q1 FY27 Consolidated Revenue ₹280.7Cr vs ₹246.7Cr (▲14% YoY) - EBITDA ₹83.3Cr vs ₹70.4Cr (▲18% YoY) - PAT ₹48.0Cr vs ₹41.1Cr (▲17% YoY) - EBITDA Margin 29.7% vs 28.5% (▲120bps)

Governance Positive

2026-08-08 19:31

- The Board of Directors considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. - Mr. Amit Mahendra Sanghvi was re-appointed as Managing Director for a term of 5 years, effective from October 1, 2026, to September 30, 2031. - Friday, September 11, 2026, was fixed as the Record Date for determining members entitled to receive the final dividend for FY 2025-26. - The revised Code of Conduct for Prevention of Insider Trading in the Securities of the Company was approved.

Financials Positive

2026-08-08 18:49

- Q1 FY27 Consolidated Revenue ₹280.57Cr vs ₹246.69Cr (▲13.73% YoY) - EBITDA ₹83.05Cr vs ₹68.40Cr (▲21.42% YoY) - PAT ₹48.01Cr vs ₹41.12Cr (▲16.75% YoY) - EBITDA Margin 29.60% vs 27.72% (▲188bps)

Financials Positive

2026-08-08 18:46

- Q1 FY27 Consolidated Revenue ₹280.57Cr vs ₹246.69Cr (▲13.73% YoY) - EBITDA ₹83.05Cr vs ₹68.40Cr (▲21.42% YoY) - PAT ₹48.01Cr vs ₹41.12Cr (▲16.76% YoY) - EBITDA Margin 29.60% vs 27.73% (▲187bps) - Board approved the re-appointment of Mr. Amit Mahendra Sanghvi as Managing Director for a term of 5 years, effective from October 1, 2026, to September 30, 2031. - The Record Date for determining members entitled to receive the final dividend for FY 2025-26 has been fixed as Friday, September 11, 2026.

Business Update Neutral

2026-07-06 16:44

- Investor Meetings Schedule - Date: 13th & 14th July 2026 - Time: 10:00 AM to 6:00 PM - Nature of Meeting: 1x1/ Group Meeting - Organised by: UBS - Venue: London, UK

Routine Neutral

2026-06-25 16:15

- Trading window for persons covered under the code will remain closed from July 01, 2026. - It will reopen 48 hours after the declaration of Unaudited Financial Results for the quarter ended June 30, 2026. - Board Meeting date for results will be intimated separately.

Business Update Neutral

2026-06-12 15:01

- Concall Schedule - Concall Date: 16th June 2026 - Concall Time: 10:00 AM to 6:00 PM - Nature of Meeting: 1x1/ Group Meeting - Organised by: Systematix - Venue: Taj Santacruz, Mumbai

Business Update Positive

2026-05-27 12:15

Shaily Engineering Plastics reported strong growth in its Healthcare and Industrial segments, driven by new product launches, market entries in Canada and the semiconductor supply chain, and new customer acquisitions. The Consumer segment experienced a degrowth due to global demand slowdown and geopolitical tensions. Operational efficiency improved, with healthcare manufacturing rejection rates dropping to 8% from 30%. Management guided for 36 million pen units for FY27 and 50 million for FY28, with margins expected to be sustainable and improving year-on-year. The company plans an initial Capex of INR100 crores for a new consumer electronics plant and has an enabling resolution to raise up to INR500 crores for future growth. Key priorities include scaling healthcare, building the Abu Dhabi facility, and ramping up new programs. The company secured an incremental INR423 crore pen injector order over four years. Debt-to-equity stands at 0.3x.

Business Update Neutral

2026-05-26 09:53

Shaily Engineering Plastics Ltd has intimated a schedule of an Analyst / Institutional Investor Group Meeting to be held on 30th May 2026, from 10:00 AM onwards in Baroda, Gujarat. Discussions will be based on publicly available information, and no Unpublished Price Sensitive Information (UPSI) will be discussed.

Business Update Neutral

2026-05-22 15:34

Shaily Engineering Plastics Limited has intimated the schedule for an Analyst / Institutional Investor Meeting. The company's officials will attend a 1x1/Group Meeting at the Investors Conference organized by 360 ONE Capital (B&K) on 28th May 2026, from 11:00 AM to 5:00 PM, at Grand Hyatt, Mumbai. Discussions will be based on publicly available information.

Business Update Neutral

2026-05-20 22:58

Shaily Engineering Plastics Ltd has informed that the audio recording of the earnings call held on 20th May 2026 is now available on the company's website. This follows previous intimations regarding the earnings call and investor presentation. The company also stated that the transcript of the call will be submitted separately.

Business Update Positive

2026-05-20 15:17

Shaily Engineering Plastics Limited announced the launch of a customer combination product incorporating its ShailyPen Neo™ device technology in Canada, following its commercial availability in India since March 2026. This launch is supported by USFDA Tentative Approval, Health Canada Notice of Compliance, and Indian Regulatory Approval for the generic Semaglutide injection, for which Shaily provides the device components.

Financials Positive

2026-05-19 21:14

Shaily Engineering Plastics reported Standalone Revenue ₹224.07Cr vs ₹203.28Cr (▲10.22% YoY), EBITDA ₹76.48Cr vs ₹52.40Cr (▲45.95% YoY), and PAT ₹48.68Cr vs ₹29.53Cr (▲64.88% YoY) for the quarter ended March 31, 2026. EBITDA Margin expanded to 34.13% vs 25.78% (▲835bps). The Board also recommended a final dividend of ₹3/- per share and approved an enabling resolution to raise up to ₹500 Cr for business expansion into high-growth adjacencies like healthcare, consumer electronics, and semiconductor components.

Ownership Neutral

2026-05-19 20:24

Shaily Engineering Plastics Ltd announced the allotment of 40,155 fully paid-up equity shares (face value Rs. 2/- each) on May 19, 2026. These shares were issued to eligible employees upon the exercise of stock options under the ESOP Plan 2019, at exercise prices of Rs. 732/- and Rs. 684/- per share. Consequently, the company's issued and paid-up equity share capital has increased from 4,59,55,093 to 4,59,95,248 equity shares.

Governance Positive

2026-05-19 20:14

Shaily Engineering Plastics Limited's Nomination and Remuneration Committee approved the grant of 3,000 Stock Options to eligible employees on May 19, 2026, under the Shaily Employee Stock Option Plan 2019. The options will vest 1/3 each year over three years and can be exercised within four years from the vesting date, with the pricing formula set at 1/3rd of the market price on the vesting date.

Financials Positive

2026-05-19 19:10

Consolidated Revenue ₹236.8 Cr vs ₹217.8 Cr (▲9% YoY), EBITDA ₹69.3 Cr vs ₹54.6 Cr (▲27% YoY), PAT ₹40.2 Cr vs ₹28.6 Cr (▲40% YoY). EBITDA Margin 29.3% vs 25.1% (▲420 bps). The company also announced a significant order win of ₹423 crore for pen injectors over four years, commenced commercial supplies to a consumer electronics customer, and signed an agreement for semiconductor trays.

Governance Positive

2026-05-19 18:21

The Board of Directors of Shaily Engineering Plastics Limited met on May 19, 2026. Key outcomes include the approval of Audited Standalone & Consolidated Financial Results for the quarter and year ended March 31, 2026, and a recommendation of a Final Dividend of ₹3/- (150%) per equity share. The Board also approved the appointment of new Internal and Cost Auditors for FY2026-27, and Mr. Chi Hung Kam as Chief Operating Officer – Healthcare. An enabling resolution was passed to raise funds up to ₹500 Crores to support business growth and diversification into new areas like consumer electronics and semiconductor components.

Financials Positive

2026-05-19 18:01

Standalone Revenue ₹224.07Cr vs ₹203.28Cr (▲10.2% YoY), EBITDA ₹62.83Cr vs ₹47.86Cr (▲31.3% YoY), PAT ₹48.68Cr vs ₹29.53Cr (▲64.9% YoY). EBITDA Margin 28.0% vs 23.5% (▲450bps).

Financials Positive

2026-05-19 17:56

Standalone Revenue ₹224Cr vs ₹203Cr (▲10% YoY), EBITDA ₹63Cr vs ₹48Cr (▲31% YoY), PAT ₹49Cr vs ₹30Cr (▲65% YoY) for the quarter ended March 31, 2026. EBITDA Margin stood at 28% vs 24% (▲400bps). The Board also recommended a final dividend of ₹3/- per equity share and approved an enabling resolution to raise up to ₹500Cr for business expansion and diversification into high-growth sectors like consumer electronics and semiconductors.

Financials Positive

2026-05-19 17:54

Standalone Revenue ₹224.07 Cr vs ₹203.28 Cr (▲10.22% YoY), EBITDA ₹76.48 Cr vs ₹52.40 Cr (▲45.95% YoY), PAT ₹48.68 Cr vs ₹29.53 Cr (▲64.87% YoY). EBITDA Margin 34.13% vs 25.78% (▲835bps).

Business Update Neutral

2026-05-15 13:57

Shaily Engineering Plastics Limited will host an earnings conference call with analysts and investors on Wednesday, May 20, 2026, at 4:00 PM IST. The call is scheduled to discuss the operational and financial performance for the quarter and fiscal year ended March 31, 2026. Key participants will include Mr. Amit Sanghvi (Managing Director) and Mr. Sanjay Shah (Chief Strategy Officer).

Business Update Neutral

2026-04-28 10:36

Shaily Engineering Plastics Limited responded to NSE/BSE queries regarding significant share price movement on April 27, 2026, stating the movement is purely market driven and confirming no undisclosed material events requiring disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.

Routine Neutral

2026-04-27 19:59

New Filing detected. See link for details.

Routine Neutral

2026-04-07 16:00

Shaily Engineering Plastics Ltd. submitted a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The certificate confirms the processing of dematerialized securities and updating of the register of members.

Routine Neutral

2026-03-25 14:18

Shaily Engineering Plastics Limited announced the closure of the trading window from April 1, 2026, until 48 hours after the declaration of audited standalone and consolidated financial results for the year ending March 31, 2026. The Board meeting date for these results will be intimated separately.

Business Update Neutral

2026-03-23 11:49

Shaily Engineering Plastics Limited announced an Analyst/Institutional Investor Group Meeting on March 27, 2026, from 10:00 AM onwards in Baroda, Gujarat. Discussions will be based on publicly available information.

SHAILY

Shaily Engineering Plastics Limited

Price Chart

Filing History

Unlock Full History